Navigation Links
ZO Skin Health, Inc. Sues Third-Party Pirates Over Illegal Sales of its Products
Date:6/21/2012

IRVINE, Calif., June 21, 2012 /PRNewswire/ -- Making good on its zero-tolerance policy for pirating, leading skincare company ZO Skin Health, Inc. has filed several trademark infringement lawsuits against third-party distributers who unlawfully acquired ZO® products and sold them online.

The first wave of suits, filed June 6 in U.S. District Court for the Southern District of Florida, accuse third-party Internet pirates, including Elite Depot operated by Web International, Inc., Web Incorporated, Aira Cosmetics Company, Aira Cosmetics, Inc., Aira Incorporated, Tonia Ryan and Derek Cavan of trademark infringement, false advertising, unfair competition and trademark dilution. The company is seeking damages and immediate injunctions to stop the Florida-based defendants from continuing to sell and advertise its products.

"These lawsuits send a clear message that we will aggressively pursue appropriate legal remedies against anyone who violates ZO Skin Health, Inc.'s trademarks," said Jim Headley, CEO and president of ZO Skin Health, Inc. "We are fiercely committed to protecting ZO®'s reputation for high-quality products developed by Dr. Zein Obagi through years of research and cutting-edge science."

The unauthorized sales were uncovered through an investigation in which the company bought numerous products from the defendants' websites bearing the ZO trademarks, including Rx products from the company's new ZO® Medical line that require a prescription before they can be obtained. The Universal Product Code, batch code and date – identifying information that helps ensure strict quality requirements and protect against counterfeits – had been altered or removed from each of the products and the packaging was damaged.

ZO Skin Health, Inc. and its medical director Zein Obagi, M.D., work directly with select physicians who are authorized to provide its treatments to patients. "These products utilize highly advanced skin therapy technology with potent anti-aging ingredients and should be used under the guidance of a licensed physician," said Headley. Third party Internet pirating and the unauthorized sales of topical drugs are illegal. "Any product bearing the ZO® name being sold over the Internet that is not through us is unauthorized and we intend to vigorously pursue all legal remedies in prosecuting the offenders," Headley added.

In order to control its brand's distribution, eliminate third-party pirates and protect the company's and its physician customers' dispensing businesses, only ZO Skin Health, Inc. is allowed to sell ZO® Skin Health and ZO® Medical products (through the Physician Affiliate Program) over the Internet. Under ZO Skin Health, Inc.'s zero-tolerance policy, anyone found to be involved in the unlawful sales of its products is automatically banned from doing future business with the company.

A copy of the federal court complaint can be found here: http://dockets.justia.com/docket/florida/flsdce/1:2012cv22099/401615/

About ZO Skin Health, Inc.
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe. Utilizing cutting-edge science and Dr. Zein Obagi's extensive clinical experience creating treatments and regimens for healthy skin, ZO Skin Health, Inc. provides comprehensive skincare programs for physicians and their patients. Committed to advancing effective treatments for healthy skin, ZO Skin Health, Inc. supports physicians' practices through skin health seminars and clinical training, and patients through a variety of educational programs. As a result, ZO Skin Health, Inc. is focused on providing products and protocols that bridge the gap between therapeutic treatments and daily care that allow patients to experience continuously healthy skin regardless of their age or unique skin condition. For more information, visit www.zoskinhealth.com.

About Zein Obagi, M.D.
Researcher, innovator, scientist, published author, lecturer and board-certified dermatologist, Dr. Zein Obagi has achieved international renown as a leading authority on skin rejuvenation. He is the ZO Skin Health, Inc. founder and medical director and is responsible for the development of new skincare treatments, protocols and products to achieve healthy skin.

Twenty years ago, Dr. Zein Obagi pioneered the concept of skin health and conceived of, and brought to market, a line of medical skincare products – the original Obagi Nu-Derm® System – that transformed aging skin. Dr. Obagi founded WorldWide Products, which produced and marketed the original Obagi Nu-Derm® System. At that time, Dr. Obagi merely intended to challenge the norms of traditional skin care. Instead he shattered the status quo. Today his ideas about skin health are no longer surprising; they have become mainstream. Subsequently WorldWide was purchased by Obagi Medical Products, Inc., a company with which Dr. Obagi no longer has any affiliation, but which retained his family name (Obagi®) as their trademark.

ZO Skin Health, Inc. and Dr. Obagi have no business relationship with Obagi Medical Products, and Obagi Medical Products does not sell or endorse using any ZO® product.  "ZO" is a registered trademark of ZO Skin Health, Inc. "Obagi" and "Obagi Nu-Derm" are registered trademarks of Obagi Medical Products, Inc.

 

 

 


'/>"/>
SOURCE ZO Skin Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
2. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
3. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
5. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
11. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... 2017 , ... The John P. McGovern Museum of Health and Medical Science ... their cognitive health, and share results with their physicians. Members and guests can sign ... website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... ... April 24, 2017 , ... Salus Telehealth, Inc. ... company’s VideoMedicine mobile platform has launched Quick Care, a new service offering on-demand ... Care provides patients with the option to request and begin a consultation with ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... Tx (PRWEB) , ... April 24, 2017 , ... ... Lief Therapeutics designed to recognize elevated anxiety levels in people with addiction who ... the Lief Smart Patch, a biosensing wearable device that monitors heart and breath ...
Breaking Medicine News(10 mins):